Danimer Scientific (DNMR)
(Delayed Data from NYSE)
$0.80 USD
+0.02 (2.18%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $0.78 -0.02 (-2.33%) 6:28 PM ET
2-Buy of 5 2
F Value D Growth A Momentum D VGM
Balance Sheet
Fiscal Year End for Danimer Scientific, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 59 | 63 | 286 | 378 | 6 |
Receivables | 16 | 20 | 21 | 7 | 5 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 25 | 33 | 25 | 14 | 7 |
Other Current Assets | 8 | 10 | 8 | 5 | 1 |
Total Current Assets | 108 | 125 | 340 | 402 | 19 |
Net Property & Equipment | 445 | 454 | 316 | 107 | 72 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 31 | 31 | 13 | 13 | 28 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 78 | 81 | 147 | 2 | 2 |
Deposits & Other Assets | 17 | 2 | 2 | 2 | 3 |
Total Assets | 698 | 712 | 839 | 546 | 145 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 5 | 15 | 21 | 11 | 8 |
Current Portion Long-Term Debt | 1 | 2 | 0 | 25 | 9 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 5 | 5 | 19 | 9 | 10 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 0 | 0 | 2 | 5 |
Total Current Liabilities | 16 | 25 | 43 | 50 | 34 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 1 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 381 | 286 | 261 | 31 | 74 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 1 | 10 | 1 | 3 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 420 | 335 | 338 | 107 | 128 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 732 | 676 | 619 | 501 | 67 |
Retained Earnings | -454 | -299 | -119 | -63 | -50 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 278 | 378 | 500 | 439 | 17 |
Total Liabilities & Shareholder's Equity | 698 | 712 | 839 | 546 | 145 |
Total Common Equity | 278 | 378 | 500 | 439 | 17 |
Shares Outstanding | 102.80 | 101.80 | 100.60 | 84.50 | NA |
Book Value Per Share | 2.70 | 3.71 | 4.97 | 5.19 | 0.00 |
Fiscal Year End for Danimer Scientific, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 59 | 77 | 91 | 120 |
Receivables | NA | 16 | 13 | 14 | 18 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 25 | 27 | 30 | 32 |
Other Current Assets | NA | 8 | 10 | 10 | 10 |
Total Current Assets | NA | 108 | 127 | 145 | 178 |
Net Property & Equipment | NA | 445 | 450 | 454 | 455 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 31 | 31 | 31 | 31 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 78 | 79 | 79 | 80 |
Deposits & Other Assets | NA | 17 | 15 | 15 | 14 |
Total Assets | NA | 698 | 721 | 744 | 779 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 5 | 4 | 4 | 6 |
Current Portion Long-Term Debt | NA | 1 | 1 | 2 | 7 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 5 | 6 | 5 | 7 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 1 | 0 | 1 | 1 |
Total Current Liabilities | NA | 16 | 15 | 15 | 25 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 381 | 379 | 376 | 373 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 1 | 1 | 3 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 420 | 417 | 414 | 423 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 732 | 719 | 705 | 691 |
Retained Earnings | NA | -454 | -415 | -375 | -335 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 278 | 304 | 330 | 356 |
Total Liabilities & Shareholder's Equity | NA | 698 | 721 | 744 | 779 |
Total Common Equity | 0 | 278 | 304 | 330 | 356 |
Shares Outstanding | 114.20 | 102.80 | 102.00 | 101.90 | 101.90 |
Book Value Per Share | 0.00 | 2.70 | 2.98 | 3.24 | 3.49 |